Clearing the smoke in chronic liver diseases

Hepatology

Volumn 51, Issue 5, 2010, Pages 1487-1490

  Zein, Claudia O ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; LEPTIN RECEPTOR; METALLOPROTEINASE; VASCULOTROPIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; CHRONIC LIVER DISEASE; CIGARETTE SMOKING; DISEASE COURSE; DISEASE EXACERBATION; EDITORIAL; FIBROGENESIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER FIBROSIS; LIVER INJURY; LONG TERM EXPOSURE; NEOVASCULARIZATION (PATHOLOGY); NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING CESSATION;

ANIMALS; CHRONIC DISEASE; FATTY LIVER; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; RATS; SMOKING;

EID: 77951462254     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23694     Document Type: Editorial

References (38)

1. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in brochogenic carcinoma. A study of 684 proved cases. J Am Med Assoc 1950;143:329-336.
2. Dolgoff S, Shcrek S, Ballard GP, Baker LA. Tobacco smoking as an etiologic factor in disease. 2. Coronary disease and hypertension. Angiology 1952;3:323-334.
3. Freund KM, Belanger AJ, D'Agostino RB, Kannel WB. The health risks of smoking. The Framingham study: 34 years of follow up. Ann Epidemiol 1993;3:417-424.
4. Office of the Surgeon General. The health consequences of smoking: a report of the surgeon general. http://www.surgeongeneral.gov/library/ smokingconsequences/index.html. Accessed March 2010.
5. Centers for Disease Control and Prevention. National Health Interview Survey 2008. http://www.cdc.gov/nchs/data/series/sr-10/sr10-242.pdf. Accessed March 2010.
6. Bataller R. Time to ban smoking in patients with chronic liver diseases. HEPATOLOGY 2006;44:1394-1396. (Pubitemid 44953642)
7. El-Zayadi AR. Heavy smoking and the liver. World J Gastroenterol 2006;12:6098-6101.
8. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 1994;10:657-664.
9. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee and cirrhosis. Am J Epidemiol 1992;136:1248-1257.
10. Marrero JA, Fontana RJ, Fu S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005;42:218-224. (Pubitemid 40143468)
11. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009;136:138-148.
12. Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol 2009;44:752-759.
13. Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship between smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006;4:797-801. (Pubitemid 43825810)
14. Hézode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al. Impact of smoking of histological liver lesions in chronic hepatitis C. Gut 2003;52:126-129. (Pubitemid 36020778)
15. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. HEPATOLOGY 2001;34:121-125. (Pubitemid 32591491)
16. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-1047. (Pubitemid 27215487)
17. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ. Cigarette smoking is associated with increased severity of hepatic fibrosis in primary biliary cirrhosis. HEPATOLOGY 2006;44:1564-1571. (Pubitemid 44953661)
18. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. HEPATOLOGY 2004;40:1387-1395. (Pubitemid 39657013)
19. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419. (Pubitemid 29258890)
20. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of NAFLD: a population-based cohort study. Gastroenterology 2005;129:113-121.
21. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355. (Pubitemid 20360647)
22. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1999;30:1356-1362.
23. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-332. (Pubitemid 23114981)
24. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001;30:540-546. (Pubitemid 32600247)
25. Yuan H, Shyy JYJ, Martin-Green M. Second hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 2009;51:535-547.
26. Chen H, Hansen MJ, Jones JE, Vlahos R, Anderson GP, Morris MJ. Detrimental metabolic effects of combining long term cigarette smoke exposure and high fat diet in mice. Am J Physiol Endocrinol Metab 2007;293:E1564-E1571. (Pubitemid 350255105)
27. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2007;293:G871-G877. (Pubitemid 47605939)
28. Bailey SM, Mantena SK, Millender-Swain T, Cakir Y, Jhala NC, Chhieng D, et al. Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease. Free Radic Biol Med 2009;46:928-938.
29. Moon J-O, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia inducible factor-1 alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G582-G592.
30. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol 2005;22:6-13.
31. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192. (Pubitemid 32246672)
32. Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002;46:959-964.
33. Azzalini L, Ferrer E, Ramalho LN, Moreno M, Domínguez M, Colmenero J, et al. Cigarette smoking etacerbates nonalcoholic fatty liver disease in obese rats. HEPATOLOGY 2010;51:1567-1576.
34. Kitade M, Yoshiji H, Kojima H, Ikenaka Y, Noguchi R, Kaji K, et al. Leptin-mediated neovascularization is a pre-requisite for progression of nonalcoholic steatohepatitis in rats. HEPATOLOGY 2006; 44:983-991. (Pubitemid 46489563)
35. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443. (Pubitemid 36929425)
36. Haenle MM, Brockmann SO, Kron M, Bertling U, Mason RA, Steinbach G, et al. Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health 2006;6:233-244. (Pubitemid 44496246)
37. Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 2006;12:5196-5200. (Pubitemid 44355917)
38. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-1066. (Pubitemid 41627993)